Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5780)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13274)
  2. Center for Hematologic Malignancies (10609)
  3. GSK Faculty (4481)
  4. Adult Leukemia (3672)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2704)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (336)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1529)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lentivirus-mediated globin gene transfer for the treatment of severe hemoglobinopathies
    Meeting Abstract

    Sadelain, M.; Rivella, S.; May, C.; Chadburn, A.; Riviere, I.
    Blood Cells, Molecules, and Diseases (2002)

    Fulltext@MSK | Save
  • Induction of human cytomegalovirus (CMV)-specific cytotoxic T-lymphocytes (CTLs) by artificial antigen presenting cells (AAPC)
    Meeting Abstract

    Papanicolaou, G.; Latouche, J.; Sadelain, M.
    Experimental Hematology (2002)

    Fulltext@MSK | Save
  • A new adult mouse model of lethal b0-thalassemia and its rescue by lentivirus-mediated globin gene transfer
    Meeting Abstract

    Rivella, S.; May, C.; Chadburn, A.; Riviere, I.; Sadelain, M.
    Experimental Hematology (2002)

    Fulltext@MSK | Save
  • Increased chemotherapy dose attenuation in elderly patients: Evidence from surveys of practice patterns in early-stage breast cancer and non-Hodgkin's lymphoma
    Meeting Abstract

    Balducci, L.; Zelenetz, A. D.; Lyman, G. H.
    Pharmacotherapy (2002)

    Fulltext@MSK | Save
  • Comparison of in vitro immune reconstitution and opportunistic infections in adults and children following unmodified unrelated BMT (cBMT)
    Meeting Abstract

    Small, T. N.; Papadopoulos, E. B.; Boulad, F.; Smith, K.; Young, J. W.; Kernan, N. A.; O'Reilly, R. J.
    Blood (2002)

    Fulltext@MSK | Save
  • Randomized study of mixed bacterial vaccine (MBV) for follicular lymphoma (FL): An evaluation over 20 years
    Meeting Abstract

    Kempin, S.; Straus, D. J.; Koziner, B.; Lee, B. J.; Mertelsmann, R. H.; Nisce, L.; Camacho, E.; Filippa, D.; Old, L.; Arlin, Z.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Phase II clinical experience with the proteasome inhibitor PS-341 in patients with indolent lymphomas
    Meeting Abstract

    O'Connor, O. A.; Moskowitz, C. H.; Wright, J. J.; Macgregor-Cortelli, B.; Straus, D.; Furst, D.; Horse-Grant, D.; Schenkein, D. P.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Clone specific PCR detects clonal cells after radiation therapy for early stage gastric MALT lymphoma
    Meeting Abstract

    Noy, A.; Yahalom, J.; Zaretsky, L.; Brett, I.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • LPAM (Alpha4 Beta7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease but not graft-versus-tumor effect
    Meeting Abstract

    Kirovski, A.; Feinman, J. W.; Alpdogan, O.; Willis, L. M.; Eng, J.; Kartono, T. H.; van den Brink, M. R. M.
    Blood (2002)

    Fulltext@MSK | Save
  • An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
    Blood (2002)

    Fulltext@MSK | Save